Haemonetics Corp
HAE76.010USD
+1.240+1.66%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
3.66BCap. mercado
21.86P/E TTM
Más Datos de Haemonetics Corp Compañía
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Información de la empresa
Símbolo de cotizaciónHAE
Nombre de la empresaHaemonetics Corp
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoMr. Christopher A. Simon
Número de empleados3023
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección125 Summer Street
CiudadBOSTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02110
Teléfono17818487100
Sitio Webhttps://www.haemonetics.com
Símbolo de cotizaciónHAE
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoMr. Christopher A. Simon
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.39K
--
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.01B
74.29%
Europe
175.66M
12.91%
Asia
92.31M
6.78%
Japan
62.41M
4.59%
other
19.54M
1.44%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.79%
The Vanguard Group, Inc.
10.59%
Neuberger Berman, LLC
9.05%
Wellington Management Company, LLP
5.46%
T. Rowe Price Investment Management, Inc.
4.57%
Other
58.53%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.79%
The Vanguard Group, Inc.
10.59%
Neuberger Berman, LLC
9.05%
Wellington Management Company, LLP
5.46%
T. Rowe Price Investment Management, Inc.
4.57%
Other
58.53%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
55.84%
Investment Advisor/Hedge Fund
49.11%
Hedge Fund
4.92%
Research Firm
4.49%
Pension Fund
1.43%
Bank and Trust
1.39%
Individual Investor
1.20%
Sovereign Wealth Fund
0.96%
Venture Capital
0.06%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
697
57.36M
119.41%
-4.15M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
2023Q1
715
51.58M
102.24%
-8.44M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
5.67M
11.79%
+31.09K
+0.55%
Mar 31, 2025
The Vanguard Group, Inc.
5.09M
10.59%
-80.50K
-1.56%
Mar 31, 2025
Neuberger Berman, LLC
4.35M
9.05%
-70.98K
-1.61%
Mar 31, 2025
Wellington Management Company, LLP
2.62M
5.46%
-1.32M
-33.38%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
2.20M
4.57%
-358.25K
-14.03%
Mar 31, 2025
State Street Global Advisors (US)
1.92M
3.99%
-28.97K
-1.49%
Mar 31, 2025
Capital Research Global Investors
1.58M
3.28%
-2.66M
-62.79%
Mar 31, 2025
River Road Asset Management, LLC
1.40M
2.9%
+1.04M
+295.76%
Mar 31, 2025
Thrivent Asset Management, LLC
1.26M
2.63%
+164.11K
+14.92%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.22M
2.54%
+40.32K
+3.41%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Neuberger Berman Small-Mid Cap ETF
2.26%
SPDR S&P Health Care Equipment ETF
1.9%
Harbor Human Capital Factor US Small Cap ETF
1.81%
Principal U.S. Small-Cap ETF
0.52%
Royce Quant Small-Cap Quality Value ETF
0.42%
Amplify Etho Climate Leadership U.S. ETF
0.35%
Gotham 1000 Value ETF
0.27%
iShares Russell 2000 Growth ETF
0.25%
Inspire Small/Mid Cap ESG ETF
0.23%
Timothy Plan US Small Cap Core ETF
0.23%
Ver más
Neuberger Berman Small-Mid Cap ETF
Proporción2.26%
SPDR S&P Health Care Equipment ETF
Proporción1.9%
Harbor Human Capital Factor US Small Cap ETF
Proporción1.81%
Principal U.S. Small-Cap ETF
Proporción0.52%
Royce Quant Small-Cap Quality Value ETF
Proporción0.42%
Amplify Etho Climate Leadership U.S. ETF
Proporción0.35%
Gotham 1000 Value ETF
Proporción0.27%
iShares Russell 2000 Growth ETF
Proporción0.25%
Inspire Small/Mid Cap ESG ETF
Proporción0.23%
Timothy Plan US Small Cap Core ETF
Proporción0.23%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
